Back to #gene editing
#gene editing Open access

Viperin as a putative antiviral effector in rainbow trout (Oncorhynchus mykiss) cells identified by CRISPR-Cas9 functional analysis following exposure to inactivated viral hemorrhagic septicemia virus

Unknown authors
Aug 2026 · Scientific Reports · 0 citations

Abstract

Viperin is recognized for its potent broad-spectrum antiviral activity; however, its role in the antiviral immune response of rainbow trout ( Oncorhynchus mykiss ) remains poorly characterized. In this study, the contribution of viperin to the innate immune response against viral haemorrhagic septicaemia virus (VHSV) was investigated using CRISPR–Cas9 gene editing of the RTS11 cell line, a monocyte/macrophage-like cell line derived from rainbow trout spleen. Cells were edited via electroporation using ribonucleoprotein (RNP) complexes targeting viperin, achieving up to 50% editing efficiency. Edited cells and corresponding controls were subsequently stimulated with heat-inactivated VHSV, and RNA sequencing was performed to assess transcriptomic changes associated with partial viperin silencing. Transcriptomic analysis revealed disruption of canonical antiviral signalling pathways, particularly those associated with the MAVS–TBK1 axis, even in the absence of viral replication. While a robust inflammatory response mediated by TRAFs and NF-κB was maintained, genes involved in apoptosis, autophagy, and phagocytosis were predominantly downregulated, suggesting a shift toward cellular survival and adaptive responses. Alternative interferon-stimulated genes were also induced, including TRIM45, indicating activation of compensatory antiviral signalling pathways. Additionally, significant upregulation of S-adenosylmethionine synthetase (MAT) and cytidine deaminase (CDA) was observed, suggesting a compensatory metabolic response that may regulate nucleotide pools available to viral machinery while supporting viperin transcription and epigenetic antiviral regulation. Collectively, these findings demonstrate that viperin plays a central role in coordinating antiviral responses in rainbow trout macrophages and is essential for proper activation of classical IFN–ISG pathways. Even partial silencing of viperin, in the presence of a non-replicative viral stimulus, shifts macrophage responses toward compensatory inflammatory and metabolic mechanisms, indicating that loss of viperin may compromise direct antiviral defence.

Read PDF

Similar papers

#gene editing Review Sep 2026

Unlocking non-model organisms with CRISPR-Cas: A roadmap for sustainable biotechnology.

It is concluded that bridging the gap between foundational CRISPR research and its real-world applications is imperative and future efforts should focus on democratizing tools via open-source platforms, advancing delivery systems, and fostering sustainable innovation through synthetic biology integration to fully realize the transformative potential of genome editing in organisms beyond model organisms.

S. Sarsaiya, Archana Jain, Jishuang Chen et al. · 2 citations
#gene editing Open access Aug 2026

Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells.

A virus-like particle (VLP)-based toolkit that delivers diverse CRISPR editing modalities to human monocytes, macrophages and dendritic cells with high efficiency while preserving viability and innate immune responsiveness is presented.

Hyuncheol Jung, Pascal Devant, Carter Ching et al. · 0 citations
#gene editing Open access Aug 2026

CRISPR/Cas9-Mediated Disruption of Duplicated Sizzled Genes Induces Twin-Tail-like Caudal Bifurcation in Goldfish (Carassius auratus)

Findings provide direct functional evidence that szl regulates median caudal patterning in goldfish and suggest that szl-dependent modulation of the Chordin/BMP network can generate twin-tail-like caudal morphology.

Huijuan Li, Xiaoying Zhang, Xiaowen Wang et al. · 0 citations
#gene editing Review Open access Aug 2026

Combining Gene Therapy with Current Modulator Treatments for Cystic Fibrosis: A Promising Area of Research

Since the development of the first cystic fibrosis transmembrane conductance regulator (CFTR) modulator in 2012, these therapies have revolutionized patients’ health. They are now the most effective treatment for people with cystic fibrosis (pwCF). In fact, elexacaftor/tezacaftor/ivacaftor and vanzacaftor/tezacaftor/deutivacaftor, the latest combination therapies consisting of a CFTR potentiator and two CFTR correctors, improved lung function by 14% in pwCF. Other modulator therapies targeting CFTR mRNA and/or protein are currently under preclinical/clinical investigation. However, due to the variant-specific nature of these therapies, about 10% of pwCF in Europe remains without effective treatment, and many treated pwCF experience various adverse events such as headaches, infections, hepatotoxicity, hypertension, and depression. Therefore, mutation-agnostic strategies such as gene therapy are needed. They could expand treatment eligibility for all pwCF and improve outcomes. In fact, nucleic acid delivery (e.g., pDNA, mRNA, oligonucleotides, genome editing) or targeting non-CFTR channels to restore ion transport represent promising future additional directions for CF therapy. This review aims to discuss a potential combination between gene therapy approaches and existing modulators to improve treatment eligibility, safety, and efficacy.

Unknown authors · 0 citations

Related blog posts

MIT News · Artificial Intelligence Aug 17, 2026

Q&A: Rethinking how innovation happens

In his latest book, Professor Eugene Fitzgerald examines the forces that turn breakthroughs into value — and why innovation resists simple formulas.